Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosaria Benedetti

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
EMBO Molecular Medicine|January 6, 2019
<i>I BET</i> on anti-FGFR to fight cancer resistanceRosaria Benedetti, Lucia Altucci
Nature Cancer|October 25, 2024
Phase separation rewires chromatin in breast cancerRosaria Benedetti, Lucia Altucci
International Journal of Cancer|July 8, 2024
Harnessing normalcy: The potential of healthy tissue for patient outcomesChiara Papulino, Rosaria Benedetti, Lucia Altucci
Antioxidants & Redox Signaling|January 3, 2014
Targeting Histone Deacetylases in Diseases: Where Are We?Rosaria Benedetti, Mariarosaria Conte, Lucia Altucci
Molecular Oncology|October 30, 2012
Trials with 'epigenetic' drugs: an updateAngela Nebbioso, Vincenzo Carafa, Rosaria Benedetti, et al.
ACS Omega|June 2, 2020
Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90Luca Pinzi, Rosaria Benedetti, Lucia Altucci, et al.
The International Journal of Biochemistry & Cell Biology|October 24, 2015
Epigenetic-based therapy: From single- to multi-target approachesRosaria Benedetti, Mariarosaria Conte, Concetta Iside, et al.
Expert Opinion on Therapeutic Targets|June 2, 2015
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemiaAngela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
Drug Discovery Today|November 9, 2020
The innovative potential of selenium-containing agents for fighting cancer and viral infectionsWesam Ali, Rosaria Benedetti, Jadwiga Handzlik, et al.
Frontiers in Endocrinology|October 31, 2017
Breast Cancer Vaccines: New InsightsRosaria Benedetti, Carmela Dell'Aversana, Cristina Giorgio, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
EMBO Molecular Medicine|January 6, 2019
<i>I BET</i> on anti-FGFR to fight cancer resistanceRosaria Benedetti, Lucia Altucci
Nature Cancer|October 25, 2024
Phase separation rewires chromatin in breast cancerRosaria Benedetti, Lucia Altucci
International Journal of Cancer|July 8, 2024
Harnessing normalcy: The potential of healthy tissue for patient outcomesChiara Papulino, Rosaria Benedetti, Lucia Altucci
Antioxidants & Redox Signaling|January 3, 2014
Targeting Histone Deacetylases in Diseases: Where Are We?Rosaria Benedetti, Mariarosaria Conte, Lucia Altucci
Molecular Oncology|October 30, 2012
Trials with 'epigenetic' drugs: an updateAngela Nebbioso, Vincenzo Carafa, Rosaria Benedetti, et al.
ACS Omega|June 2, 2020
Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90Luca Pinzi, Rosaria Benedetti, Lucia Altucci, et al.
The International Journal of Biochemistry & Cell Biology|October 24, 2015
Epigenetic-based therapy: From single- to multi-target approachesRosaria Benedetti, Mariarosaria Conte, Concetta Iside, et al.
Expert Opinion on Therapeutic Targets|June 2, 2015
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemiaAngela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
Drug Discovery Today|November 9, 2020
The innovative potential of selenium-containing agents for fighting cancer and viral infectionsWesam Ali, Rosaria Benedetti, Jadwiga Handzlik, et al.
Frontiers in Endocrinology|October 31, 2017
Breast Cancer Vaccines: New InsightsRosaria Benedetti, Carmela Dell'Aversana, Cristina Giorgio, et al.
Pageof 8